Neuroscience
An interesting read. I always aimed for 6th-grade reading level myself, so it surprised me to read of this finding:
Informed Consent Forms Target 11th Grade Readers
By Ed Silverman
Pharmalot
December 12th, 2011 // 9:29 am
Read the full blog post
- Alzheimer's Disease: A Wrap For Bap
Trials for Alzheimer’s Drug Halted After Poor Results By KATIE THOMAS The New York Times 06 August 2012 Read full article ---Corporate Press Release: Read the releaseCommentary from the In The Pipeline blog: In The PipelineCommentary from Pharmalot:...
- Alzheimer's: Bapineuzumab And Solanezumab
Survey shows dim faith in Lilly, Pfizer Alzheimer's drugs Ransdell Pierson | Reuters The Chicago Tribune June 19, 2012 [snip] "Results from the survey of 146 investors were released late on Tuesday by Mark Schoenebaum, a pharmaceutical analyst for...
- Clinical Trials: Moscow Rules
An interesting posting on the Pharmalot blog today: Russian Trial Rules Are A ‘Serious Blow’ To Pharma By Ed Silverman November 29th, 2011 // 9:56 am Read the blog post...
- Pharmalot Interview With Dr. Michael Rogawski About Reporting Data In Clinical Trials
A fine read from the Pharmalot blog: All Trial Data Must Be Disclosed: Rogawski Explains By Ed Silverman October 5th, 2011 - 9:36 am Read the full blog posting...
- Become An Intern With A Wider Circle And Help Dc 3rd Graders Learn How To Read!
Third grade is a critical year, marking the transition of a student from learning to read to reading to learn. Too often, students who test below proficiency level in reading at the end of third grade fall further and further behind in subsequent grades;...
Neuroscience
From Pharmalot: Informed Consent Form Readibility
An interesting read. I always aimed for 6th-grade reading level myself, so it surprised me to read of this finding:
Informed Consent Forms Target 11th Grade Readers
By Ed Silverman
Pharmalot
December 12th, 2011 // 9:29 am
Read the full blog post
- Alzheimer's Disease: A Wrap For Bap
Trials for Alzheimer’s Drug Halted After Poor Results By KATIE THOMAS The New York Times 06 August 2012 Read full article ---Corporate Press Release: Read the releaseCommentary from the In The Pipeline blog: In The PipelineCommentary from Pharmalot:...
- Alzheimer's: Bapineuzumab And Solanezumab
Survey shows dim faith in Lilly, Pfizer Alzheimer's drugs Ransdell Pierson | Reuters The Chicago Tribune June 19, 2012 [snip] "Results from the survey of 146 investors were released late on Tuesday by Mark Schoenebaum, a pharmaceutical analyst for...
- Clinical Trials: Moscow Rules
An interesting posting on the Pharmalot blog today: Russian Trial Rules Are A ‘Serious Blow’ To Pharma By Ed Silverman November 29th, 2011 // 9:56 am Read the blog post...
- Pharmalot Interview With Dr. Michael Rogawski About Reporting Data In Clinical Trials
A fine read from the Pharmalot blog: All Trial Data Must Be Disclosed: Rogawski Explains By Ed Silverman October 5th, 2011 - 9:36 am Read the full blog posting...
- Become An Intern With A Wider Circle And Help Dc 3rd Graders Learn How To Read!
Third grade is a critical year, marking the transition of a student from learning to read to reading to learn. Too often, students who test below proficiency level in reading at the end of third grade fall further and further behind in subsequent grades;...